Histologic grade in advanced ovarian cancer

Area of Science:

• Oncology
• Pathology
• Chemotherapy

Background:

• Histologic grade is a critical prognostic indicator in advanced epithelial ovarian tumors (Stages III-IV).
• Cytologic grading systems, such as modified Broders' grades, can stratify patients based on tumor characteristics.
• Understanding these prognostic factors is essential for tailoring treatment strategies.

Purpose of the Study:

• To evaluate the prognostic significance of histologic grade in advanced epithelial ovarian cancer.
• To determine if modified Broders' grades correlate with differential responses to chemotherapy.
• To assess the impact of chemotherapy on survival across different tumor grades.

Main Methods:

• Retrospective analysis of patients with advanced epithelial ovarian tumors.
• Application of a modified Broders' grading system (I-IV) based on cytologic detail.
• Comparison of survival outcomes between patients receiving single-agent versus combination chemotherapy.

Main Results:

• Histologic grade was a significant prognostic factor for survival in advanced disease.
• Modified Broders' grades identified patient groups with varying responses to chemotherapy.
• Combination chemotherapy improved survival primarily in patients with grade II and III lesions.
• Survival for grade I and IV lesions was not significantly influenced by chemotherapy regimen choice.

Conclusions:

• Histologic grade, specifically using modified Broders' classification, is crucial for predicting survival in advanced epithelial ovarian cancer.
• The differential response to chemotherapy based on grade suggests a need for personalized treatment approaches.
• Modified Broders' grades should be incorporated as a stratification factor in prospective clinical trials for advanced disease.